Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
600602 INESA Intelligent Tech Inc.
- 23.16
- -0.91-3.78%
Not Open Apr 1 15:00 CST
31.68BMarket Cap156.49P/E (TTM)
24.07High23.01Low690.48KlotVolume24.07Open24.07Pre Close1.62BTurnover6.43%Turnover Ratio156.49P/E (Static)1.37BShares30.2652wk High6.66P/B24.88BFloat Cap9.1652wk Low26.48Limit Up1.07BShs Float30.26Historical High21.66Limit Down4.40%Amplitude0.01Historical Low0.04Dividend TTM23.45Avg Price378.75KlotAsk0.19%Div YieldTTM100Lot Size262.69KlotBid
INESA Intelligent Tech Inc. Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 6.82%5.62B | 8.25%4.01B | 15.70%2.89B | 28.66%1.43B | 16.09%5.26B | 19.67%3.71B | 32.44%2.5B | -3.11%1.11B | -9.19%4.53B | -12.48%3.1B |
| Operating revenue | 6.82%5.62B | 8.25%4.01B | 15.70%2.89B | 28.66%1.43B | 16.09%5.26B | 19.67%3.71B | 32.44%2.5B | -3.11%1.11B | -9.19%4.53B | -12.48%3.1B |
| Other operating revenue | -24.04%678.55K | ---- | 136.77%1.23M | ---- | -64.64%893.28K | ---- | -88.23%518.54K | ---- | -98.68%2.53M | ---- |
| Total operating cost | 4.69%5.38B | 7.33%3.85B | 14.69%2.76B | 25.64%1.36B | 15.65%5.13B | 17.23%3.58B | 27.48%2.4B | -3.38%1.08B | -6.03%4.44B | -9.59%3.06B |
| Operating cost | 5.13%4.54B | 7.23%3.23B | 15.56%2.35B | 29.71%1.16B | 18.62%4.32B | 19.49%3.01B | 31.79%2.03B | -2.93%897.75M | -7.10%3.64B | -11.40%2.52B |
| Operating tax surcharges | 14.08%18.92M | 29.35%11.35M | 17.64%6.3M | -1.17%2.78M | 22.50%16.59M | 20.14%8.78M | 21.21%5.36M | 18.01%2.82M | -30.02%13.54M | -30.81%7.31M |
| Operating expense | -9.61%236.61M | -2.69%191.82M | -6.65%120.39M | -5.03%57.95M | 17.08%261.76M | 25.01%197.12M | 27.89%128.97M | 8.63%61.01M | 2.44%223.56M | 4.78%157.68M |
| Administration expense | 4.93%289.58M | -0.66%188.61M | 0.46%121.45M | -10.72%58.52M | -5.42%275.97M | 2.26%189.86M | 4.13%120.9M | 4.36%65.54M | 3.56%291.78M | -0.12%185.66M |
| Financial expense | 29.57%-76.99M | 21.95%-58.92M | 26.38%-40.1M | 30.76%-21.54M | -22.81%-109.31M | -13.51%-75.5M | -27.20%-54.48M | -87.28%-31.1M | -8.36%-89M | -4.13%-66.51M |
| -Interest expense (Financial expense) | -29.82%5.87M | 30.73%7.05M | 37.66%4.57M | 113.71%2.38M | 62.93%8.37M | 107.92%5.39M | 32.88%3.32M | -9.20%1.12M | -28.42%5.14M | -52.44%2.59M |
| -Interest Income (Financial expense) | 28.95%-84.82M | 17.14%-67.06M | 22.33%-45.31M | 25.33%-24.33M | -24.89%-119.38M | -15.14%-80.93M | -26.78%-58.34M | -79.60%-32.59M | -5.23%-95.59M | -0.18%-70.29M |
| Research and development | -0.90%369.45M | 12.72%287.4M | 17.32%199.72M | 13.25%98.15M | 3.28%372.82M | 0.01%254.97M | 3.40%170.23M | -4.70%86.66M | -2.55%360.98M | -0.49%254.94M |
| Credit Impairment Loss | -1,478.35%-36.56M | -1,724.47%-11.9M | -422.83%-15.24M | -169.76%-5.98M | 88.72%-2.32M | 94.73%-652.07K | 121.30%4.72M | 171.81%8.57M | -365.38%-20.54M | -64.94%-12.37M |
| Asset Impairment Loss | -30,880.63%-20.61M | 51.01%-226.55K | 217.05%251.48K | 118.99%78.93K | 100.17%66.96K | -124.75%-462.49K | -112.09%-214.84K | -205.95%-415.52K | -8.51%-38.8M | 382.34%1.87M |
| Other net revenue | -101.03%-1.2M | -74.82%18.26M | -238.15%-1.18M | -104.45%-630.85K | 17.19%116.5M | -49.20%72.49M | -99.20%852.66K | -82.17%14.17M | 504.66%99.41M | 476.38%142.7M |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 97.60%-295.83K | 97.65%-295.83K |
| Invest income | -72.20%21.68M | -78.04%14.3M | 173.01%5.35M | 323.32%184.47K | -41.14%78M | -52.05%65.1M | -106.11%-7.33M | -100.09%-82.6K | 269.07%132.51M | 461.77%135.77M |
| -Including: Investment income associates | -2.67%4.88M | 72.08%-2.08M | -50.41%-11.03M | 323.32%184.47K | 122.61%5.02M | 58.87%-7.47M | 78.41%-7.33M | 97.62%-82.6K | -226.66%-22.19M | -319.84%-18.15M |
| Asset deal income | 398.66%1.19M | 37,316.33%1.2M | 1,814.32%61.55K | 216.66%48K | -55.24%238.52K | 129.56%3.22K | 163.15%3.22K | ---41.15K | 20,378.99%532.9K | -100.90%-10.88K |
| Other revenue | -18.28%33.1M | 74.88%14.88M | 128.37%8.39M | -18.09%5.03M | 55.84%40.51M | -52.01%8.51M | -50.73%3.68M | 112.64%6.15M | -21.28%25.99M | -11.98%17.73M |
| Operating profit | 0.10%245.88M | -5.60%183.85M | 38.67%133.29M | 63.85%64.29M | 26.85%245.62M | 6.58%194.75M | -11.11%96.12M | -61.63%39.24M | -31.99%193.63M | 0.33%182.73M |
| Add:Non operating Income | -56.19%2.4M | -84.55%2.21M | -85.62%1.39M | -82.85%1.22M | -54.98%5.47M | 224.55%14.33M | 233.57%9.68M | 895.23%7.09M | -59.04%12.16M | -66.01%4.41M |
| Less:Non operating expense | 534.37%3.46M | 31.31%612.67K | 131.44%538.04K | -99.32%1.58K | -77.88%545.6K | -37.92%466.58K | -58.51%232.48K | -57.97%231.19K | -0.39%2.47M | -52.72%751.6K |
| Total profit | -2.29%244.81M | -11.10%185.45M | 27.07%134.15M | 42.09%65.51M | 23.23%250.55M | 11.92%208.61M | -4.44%105.57M | -54.99%46.1M | -34.82%203.33M | -3.69%186.39M |
| Less:Income tax cost | 3.02%22.95M | -46.35%18.35M | 52.94%12.66M | 5.21%6.93M | 46.92%22.28M | 18.10%34.2M | -68.03%8.28M | -78.67%6.58M | -23.12%15.16M | 95.42%28.96M |
| Net profit | -2.81%221.86M | -4.19%167.1M | 24.87%121.49M | 48.23%58.58M | 21.32%228.28M | 10.78%174.41M | 15.02%97.29M | -44.78%39.52M | -35.61%188.16M | -11.90%157.44M |
| Net profit from continuing operation | -2.81%221.86M | -4.19%167.1M | 24.87%121.49M | 48.23%58.58M | 21.32%228.28M | 10.78%174.41M | 15.02%97.29M | -44.78%39.52M | -35.61%188.16M | -11.90%157.44M |
| Less:Minority Profit | -44.95%19.47M | -50.11%9.17M | 88.64%8.48M | 33.18%-1.43M | 380.34%35.36M | 285.41%18.39M | 170.80%4.5M | -18.20%-2.15M | -79.27%7.36M | -44.42%4.77M |
| Net profit of parent company owners | 4.92%202.39M | 1.22%157.93M | 21.78%113M | 44.04%60.02M | 6.70%192.91M | 2.20%156.02M | 2.04%92.79M | -43.22%41.67M | -29.57%180.8M | -10.26%152.67M |
| Earning per share | ||||||||||
| Basic earning per share | 4.96%0.148 | 1.23%0.1155 | 21.65%0.0826 | 46.67%0.044 | 6.82%0.141 | 2.24%0.1141 | 2.11%0.0679 | -44.44%0.03 | -29.79%0.132 | -10.29%0.1116 |
| Diluted earning per share | 4.96%0.148 | 1.23%0.1155 | 21.65%0.0826 | 46.67%0.044 | 6.82%0.141 | 2.24%0.1141 | 2.11%0.0679 | -44.44%0.03 | -29.79%0.132 | -10.29%0.1116 |
| Other composite income | 40.81%181.84K | -138.17%-115.39K | -85.53%52.66K | 118.96%12.85K | -77.76%129.13K | 1,340.72%302.33K | -4.73%363.89K | -161.93%-67.75K | 565.95%580.74K | 0.00%-24.37K |
| Other composite income of parent company owners | 40.81%181.84K | -138.17%-115.39K | -85.53%52.66K | 118.96%12.85K | -77.76%129.13K | 1,340.72%302.33K | -4.73%363.89K | -161.93%-67.75K | 565.95%580.74K | 0.00%-24.37K |
| Total composite income | -2.78%222.04M | -4.42%166.99M | 24.46%121.54M | 48.52%58.6M | 21.01%228.4M | 10.99%174.71M | 14.93%97.65M | -44.85%39.45M | -35.38%188.75M | -11.91%157.41M |
| Total composite income of parent company owners | 4.94%202.58M | 0.95%157.81M | 21.36%113.06M | 44.31%60.03M | 6.43%193.04M | 2.41%156.32M | 2.02%93.16M | -43.29%41.6M | -29.31%181.38M | -10.27%152.64M |
| Total composite income of minority owners | -44.95%19.47M | -50.11%9.17M | 88.64%8.48M | 33.18%-1.43M | 380.34%35.36M | 285.41%18.39M | 170.80%4.5M | -18.20%-2.15M | -79.27%7.36M | -44.42%4.77M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.